SCHEMBL3194751

SCHEMBL3194751

COC(=O)Cn1c(C)c(C)c2cc(C#N)nc(N3CCc4ccccc4C3)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.41
KDM4E B2RXH2 4/20 0.41
MAPT P10636 4/20 0.41
ALDH1A1 P00352 4/20 0.41
TP53 P04637 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HTT P42858 2/20 0.41
TSHR P16473 3/20 0.41
PTK2B Q14289 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
GRIN2D O15399 3/20 0.38
GRIN3B O60391 3/20 0.38
GRIN1 Q05586 3/20 0.38
GRIN2A Q12879 3/20 0.38
GRIN2B Q13224 3/20 0.38
GRIN2C Q14957 3/20 0.38
GRIN3A Q8TCU5 3/20 0.38
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3195045 0.92 HPGD (0.45) HPGDKDM4EMAPTALDH1A1TP53
SCHEMBL1735781 0.86 KDM4E (0.44) HPGDKDM4EMAPTALDH1A1TP53
SCHEMBL1736817 0.85 KDM4E (0.42) HPGDKDM4EMAPTALDH1A1TP53
SCHEMBL1738200 0.85 LIPE (0.39) HPGDKDM4EMAPTALDH1A1TP53
SCHEMBL1737195 0.85 KDM4E (0.43) HPGDKDM4EMAPTALDH1A1TP53
SCHEMBL1737207 0.84 HPGD (0.39) HPGDKDM4EMAPTALDH1A1TP53
SCHEMBL1737876 0.83 KDM4E (0.41) HPGDKDM4EMAPTALDH1A1TP53
SCHEMBL1736503 0.83 KDM4E (0.39) HPGDKDM4EMAPTALDH1A1TP53
SCHEMBL3845463 0.83 MEN1 (0.40) HPGDKDM4EMAPTALDH1A1TP53
SCHEMBL1737237 0.83 KDM4E (0.40) HPGDKDM4EMAPTALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US claimed
US-8188114-B2 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2012-05-29 US disclosed
US-7662832-B2 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-02-16 US disclosed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H HPGD 148/4885KDM4E 1107/4885MAPT 3920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.